Interest: U.S. Secretary of Energy Dr. Ernest Moniz on Monday joined a bevy of leaders in the city's technology-transfer arena for some frank discussion about the future of technology transfer in New Mexico. But the answers Moniz had weren't exactly what people wanted to hear.
Interest: Hsu and his University of Florida-spawned company, Prometheon Pharma, are looking to change that with an insulin patch they are trying to bring to market by 2018 as an alternative to needle injections.
Interest: Purnendu Dasgupta, who did a decade of research, has developed an environmentally friendly field analyzer for arsenic levels in water. Thanks to nearly $200,000 from the National Science Foundation, Dasgupta is a step closer to bringing his analyzer to market.
Interest: Equity crowdfunding has become something of a legend in the startup industry. It is being hailed (and criticized) for being a brand new conduit for startups to raise capital and for entrepreneurs to launch new endeavors. It's true that a great amount of potential capital could be unlocked by including the non-accredited investors in the startup industry.
Interest: Venture capitalists worldwide are highly confident about the U.S. despite a belief by U.S. investors that government can’t get out of its own way, a survey found.
Global investor confidence in the U.S. was 4.03 on a 1-to-5 scale, the highest recorded for any nation in three years by the annual survey conducted by the National Venture Capital Association and Deloitte & Touche LLP. U.S.-based investors gave their country an even higher rating of 4.17, up 11% from last year.
Interest: This recent Techcrunch article about startup activity in Seattle shows how the University of Washington and the City of Seattle are working together to make the city more attractive to those looking to launch their start-up. With the city’s Office of Economic Development (OED) taking the lead (and going so far as to purchase and run a startup hub website) the partnership is addressing several key issues: office space, zoning, and collaboration support.
NCET2 Launches its webinar schedule for the 2nd Quarter of 2014. Bringing together expert speakers and resource persons, the offerings for this quarter include a free webinar series with the US Small Business Administration on the current SBIR/STTR programs and the Application Online Workshop series in Applying to the NSF and NIH SBIR Programs for First-time Applicants. For those interested in developing their research into a product, join us on April 15 with Dr. Art Gooray as he facilitates the 5-session certificate course on "Product Development and the Innovation Process for Researchers."
Interest: # 8. Corporate venture capital picks up the slack
As traditional venture firms pull away from funding life sciences start-ups, corporate capital will pick up the slack in 2014. With many corporations cash rich – but R&D poor – new venture funds may be a solution for stagnating innovation.
Interest: Based on healthcare industry predictions made last year by leaders and analysts, this year should have brought a re-evaluation of meaningful use (yep), a quantified self movement that would move mainstream (ehhh), more M&A activity in the industry (definitely) and the emergence of interoperability as a competitive benchmark for providers (not quite yet?).
Join the SBA for the next webinar installment with Ms. Susan Nichols, Program Manager of the DARPA SBIR/STTR programs, which reflect the Agency's compliance with the small business program goals set by DoD's Office of Small Business Programs. The webinar will take place today Thursday November 21st at 3:00PM EDT
If you are the owner, leader or manager of an entrepreneurial organization who wants to see their business involved in the DARPA space, then this is the webinar for you.
Interest: The health benefits of the National
Institutes of Health (NIH) research
support are clear: investment in
NIH directly leads to better medicines,
equipment and delivery systems
to prevent and cure disease. Additionally
NIH plays a notable role as
an economic engine, helping maintain
Interest: A few months ago a venture capital company I consult for asked me to visit the offices of Baker–Calling, a Santa Monica–based start-up trying to build a better microphone for use in smartphones and tablets. Baker–Calling’s founder, Robert Littrell, has been working on this problem for eight years—first while earning an engineering PhD at the University of Michigan, and now as the CEO of his five-person company.
Interest: When you think about what startups and their venture capitalists should focus on, does corporate governance quickly come to mind? Probably not. But it should. As with public company boards of directors, boards of venture backed companies should emphasize strategy execution and risk oversight. Startups, though, face special challenges. - See more at: http://www.dypadvisors.com/2010/10/12/three-corporate-governance-issues-venture-capital-backed-startups/#sthash.1jYkrokY.dpuf
Interest: With Bradenton emerging as an up-and-coming hip place, though, opportunities to engage and recruit young entrepreneurs and technology wizards are in play. This week's news that the Friendly City is primed to become home to a business incubator is another indication of Bradenton's bright future.
Interest: Mary Phillips has been named director for the Office of Research Development, a new unit within the Research Office, effective Dec. 1.
Phillips is associate director for the Office for Commercialization and Corporate Development, where she oversees the management of intellectual property and licensing of OSU inventions. Phillips will work with faculty and academic units to identify and pursue major funding opportunities, including federal, nonprofit and corporate sources.
Interest: Researchers, led by University of Washington (UW) physicist Jens Gundlach, have developed a nanopore sequencing technology that is capable of reading the sequence of a single DNA molecule. In this system, the DNA is pulled through a nanopore while an ion current through the pore electronically reads the DNA's sequence. The nanopore is an engineered protein developed specifically for DNA sequencing by Gundlach's team in collaboration with Michael Niederweis, a microbiologist at the University of